Althoff Friederike C, Xu Xinling, Wachtendorf Luca J, Shay Denys, Patrocinio Maria, Schaefer Maximilian S, Houle Timothy T, Fassbender Philipp, Eikermann Matthias, Wongtangman Karuna
Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
Department of Anesthesiology, Duesseldorf University Hospital, Duesseldorf, Germany.
BMJ Open. 2021 Apr 14;11(4):e048509. doi: 10.1136/bmjopen-2020-048509.
To assess variability in the intraoperative use of non-depolarising neuromuscular blocking agents (NMBAs) across individual anaesthesia providers, surgeons and hospitals.
Retrospective observational cohort study.
Two major tertiary referral centres, Boston, Massachusetts, USA.
265 537 adult participants undergoing non-cardiac surgery between October 2005 and September 2017.
We analysed the variances in NMBA use across 958 anaesthesia and 623 surgical providers, across anaesthesia provider types (anaesthesia residents, certified registered nurse anaesthetists, attendings) and across hospitals using multivariable-adjusted mixed effects logistic regression. Intraclass correlations (ICC) were calculated to further quantify the variability in NMBA use that was unexplained by other covariates. Procedure-specific subgroup analyses were performed.
NMBAs were used in 183 242 (69%) surgical cases. Variances in NMBA use were significantly higher among individual surgeons than among anaesthesia providers (variance 1.32 (95% CI 1.06 to 1.60) vs 0.24 (95% CI 0.19 to 0.28), p<0.001). Procedure-specific subgroup analysis of hernia repairs, spine surgeries and mastectomies confirmed our findings: the total variance in NMBA use that was unexplained by the covariate model was higher for surgeons versus anaesthesia providers (ICC 37.0% vs 13.0%, 69.7% vs 25.5%, 69.8% vs 19.5%, respectively; p<0.001). Variances in NMBA use were also partially explained by the anaesthesia provider's hospital network (Massachusetts General Hospital: variance 0.35 (95% CI 0.27 to 0.43) vs Beth Israel Deaconess Medical Center: 0.15 (95% CI 0.12 to 0.19); p<0.001). Across provider types, surgeons showed the highest variance, and anaesthesia residents showed the lowest variance in NMBA use.
There is wide variability across individual surgeons and anaesthesia providers and institutions in the use of NMBAs, which could not sufficiently be explained by a large number of patient-related and procedure-related characteristics, but may instead be driven by preference. Surgeons may have a stronger influence on a key aspect of anaesthesia management than anticipated.
评估不同麻醉医生、外科医生和医院在术中使用非去极化神经肌肉阻滞剂(NMBAs)的差异。
回顾性观察队列研究。
美国马萨诸塞州波士顿的两家主要三级转诊中心。
2005年10月至2017年9月期间接受非心脏手术的265537名成年参与者。
我们使用多变量调整的混合效应逻辑回归分析了958名麻醉医生和623名外科医生、不同类型麻醉医生(麻醉住院医师、注册护士麻醉师、主治医师)以及不同医院之间NMBAs使用的差异。计算组内相关系数(ICC)以进一步量化NMBAs使用中无法用其他协变量解释的差异。进行了特定手术的亚组分析。
183242例(69%)手术病例使用了NMBAs。个体外科医生之间NMBAs使用的差异显著高于麻醉医生(差异为1.32(95%CI 1.06至1.60)对0.24(95%CI 0.19至0.28),p<0.001)。对疝气修补术、脊柱手术和乳房切除术进行的特定手术亚组分析证实了我们的发现:协变量模型无法解释的NMBAs使用总差异,外科医生高于麻醉医生(ICC分别为37.0%对13.0%、69.7%对25.5%、69.8%对19.5%;p<0.001)。麻醉医生所在的医院网络也部分解释了NMBAs使用的差异(麻省总医院:差异为0.35(95%CI 0.27至0.43)对贝斯以色列女执事医疗中心:0.15(95%CI 0.12至0.19);p<0.001)。在不同类型的医生中,外科医生在NMBAs使用方面差异最大,麻醉住院医师差异最小。
在NMBAs的使用上,个体外科医生、麻醉医生和机构之间存在很大差异,大量与患者和手术相关的特征无法充分解释这种差异,而可能是由偏好驱动的。外科医生对麻醉管理的一个关键方面可能比预期有更大的影响。